ArticleNature communications2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Abstract read
In one paragraph
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- SMARCB1/INI1-deficient peripheral T-cell lymphoma: two cases expanding the spectrum of an emerging entity and a review of the literature.Virchows Archiv : an international journal of pathology · 2026Article
- Post-Translational Modifications in Cancer-Associated CD8⁺ T-Cell Exhaustion: Mechanisms and Therapeutic Opportunities.International journal of biological sciences · 2026Review
- Integrative multi-omics and Mendelian randomization identify WWOX and THBS2 as potential therapeutic targets in mature T/NK-cell lymphoma.Journal of translational medicine · 2025Article
- An aggressive hematolymphoid neoplasm with homozygousHaematologica · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
55 authors.
Anja Fischer *Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany.ORCID 0000-0002-7145-2544
Thomas K Albert *Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.ORCID 0000-0002-2488-0706
Natalia Moreno *Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Marta Interlandi *Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Jana MormannDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Selina GlaserInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.
Paurnima PatilInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.
Flavia W de FariaDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Mathis RichterInstitute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany.ORCID 0000-0002-3110-6137
Archana VermaDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Sebastian T BalbachDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.ORCID 0000-0003-0212-5758
Rabea WagenerInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.
Susanne BensInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.ORCID 0009-0008-5263-495X
Sonja DahlumInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.
Carolin GöbelDepartment of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany.ORCID 0000-0002-7345-2089
Daniel MünterDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.ORCID 0000-0001-8823-0238
Clara InserteInstitute of Medical Informatics, University of Münster, 48149, Münster, Germany.
Monika GrafDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Eva KremerDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Viktoria MelcherDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Gioia Di StefanoPathological Anatomy Section, Careggi University Hospital, Florence, Italy.
Raffaella SantiPathological Anatomy Section, Careggi University Hospital, Florence, Italy.
Alexander ChanDepartment of Pathology, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.ORCID 0000-0001-5884-8424
Ahmet DoganDepartment of Pathology, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.ORCID 0000-0001-6576-5256
Jonathan BushDivision of Anatomical Pathology, British Columbia Children's Hospital and Women's Hospital and Health Center, Vancouver, BC, Canada.ORCID 0000-0001-9432-2390
Martin HasselblattInstitute of Neuropathology, University Hospital Münster, 48149, Münster, Germany.
Sylvia ChengDivision of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Signe SpetalenDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Alexander FossåDepartment of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway.
Wolfgang HartmannDivision of Translational Pathology, Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude D17, 48149, Münster, Germany.ORCID 0000-0002-7609-5021
Heidi HerbrüggenDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Stella RobertDepartment of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany.
Florian OyenDepartment of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany.
Martin DugasInstitute of Medical Informatics, University of Münster, 48149, Münster, Germany.ORCID 0000-0001-9740-0788
Carolin WalterInstitute of Medical Informatics, University of Münster, 48149, Münster, Germany.
Sarah SandmannInstitute of Medical Informatics, University of Münster, 48149, Münster, Germany.ORCID 0000-0002-5011-0641
Julian VargheseInstitute of Medical Informatics, University of Münster, 48149, Münster, Germany.ORCID 0000-0002-7206-3719
Claudia RossigDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Ulrich SchüllerDepartment of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany.ORCID 0000-0002-8731-1121
Alexandar TzankovInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-1100-3819
Martin B PedersenDepartment of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Francesco A d'AmoreDepartment of Hematology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-4032-6633
Karin MellgrenDepartment of Pediatric Oncology and Hematology, Sahlgrenska University Hospital, The Queen Silvia Children's Hospital, Gothenburg, Sweden.ORCID 0000-0002-9424-3200
Udo KontnySection of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatric and Adolescent Medicine, RWTH Aachen University Hospital, Aachen, Germany.ORCID 0000-0002-3072-6772
Venkatesh KancherlaInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Luis VelozaInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Edoardo MissiagliaInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Virginie FataccioliINSERM U955, Université Paris-Est, Créteil, France.
Philippe GaulardDépartement de Pathologie, Hôpitaux Universitaires Henri Mondor, AP-HP, INSERM U955, Université Paris Est Créteil, Créteil, France.
Birgit BurkhardtDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.ORCID 0000-0002-1151-829X
Oliver SoehnleinInstitute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany.ORCID 0000-0002-7854-0694
Wolfram KlapperDepartment of Pathology, Haematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0001-7208-4117
Laurence de LevalInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland.ORCID 0000-0003-3994-516X
Reiner SiebertInstitute of Human Genetics, Ulm University Medical Center, Ulm, Germany.
Kornelius KerlDepartment of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany. Kornelius.kerl@ukmuenster.de.ORCID 0000-0002-5676-8102
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MDeutsche Krebshilfe (German Cancer Aid) 111784NCI NIH HHS P30 CA008748
Abstract
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous group of malignancies with poor outcome. Here, we identify a subgroup, PTCL-NOS
Indexed as
DNA MethylationGene Expression Regulation, NeoplasticHistone Deacetylase InhibitorsLymphoma, T-Cell, PeripheralSMARCB1 ProteinTumor MicroenvironmentAnimalsCell Line, TumorFemaleHumansMaleMiceSingle-Cell AnalysisVorinostatHistone Deacetylase InhibitorsSMARCB1 ProteinSMARCB1 protein, humanSmarcb1 protein, mouseVorinostat
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.